-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - C-11
Interventions for
Substance Use
Disorders in
Adolescents: A
Systematic Review37
What … behavioral, pharmacologic,
and combined
interventions compared
with placebo or no active
treatment for substance … use disorders and
problematic substance use
in adolescents to achieve
abstinence, reduce
quantity … Interventions for Substance Use Disorders in
Adolescents: A Systematic Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - treatment
of eating disorders, insomnia, attention-deficit
hyperactivity disorder (ADHD), anxiety, and substance … abuse. … abuse, and Tourette’s
syndrome. … dementia in elderly patients, depression, eating
disorders, insomnia, OCD, personality disorder,
PTSD, substance … use disorders, and Tourette’s
syndrome.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
January 01, 2022 - Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update
Comparative Effectiveness Review
Number 250
Living Systematic Review on Cannabis and
Other Plant-Based Treatments for Chronic
Pain: 2022 Update
Evide…
-
effectivehealthcare.ahrq.gov/products/traumatic-brain-injury-rehabilitation/research-protocol
July 12, 2011 - education, race/ethnicity, income, vocational status, prior TBI, and psychiatric conditions (i.e., substance … abuse, etc.).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation_research-protocol.pdf
October 25, 2010 - education, race/ethnicity, income, vocational status, prior TBI, and psychiatric conditions (i.e.,
substance … abuse, etc.).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - • Comorbidities, including substance abuse and
ADHD?
• Cotreatment versus monotherapy?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_executive.pdf
April 01, 2012 - 1
Comparative Effectiveness Review
Number 62
Treatment for Depression After Unsatisfactory
Response to SSRIs
Executive Summary
Background
Depression is a complex mental illness
associated with disability and reduced
quality of life for the person with
depression, as well as substantial societal
burden. Major …
-
effectivehealthcare.ahrq.gov/products/depression-harms/research-protocol
February 07, 2018 - cognitive impairment
Nursing home setting
≥2 physical (i.e. non-psychiatric) comorbidities
History of substance … abuse
Frailty
Early versus late onset MDD
Polypharmacy, defined as 5 or more concurrent prescription
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - physical activity, education and
intellectual engagement, social engagement, alcohol,
smoking, and substance … abuse, medications, and vitamins.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - physical activity, education and
intellectual engagement, social engagement, alcohol,
smoking, and substance … abuse, medications, and vitamins.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
January 16, 2023 - (e.g., age, race, ethnicity, sex, socioeconomic status)
• Comorbidities, including past or current substance … use disorders, mental health disorders,
medical comorbidities, and high risk for opioid use disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - clearance of 30 ml or less/minute;
an unstable medical condition;
hisotyr of cancer or alcohol or drug … abuse; lactationl concomitant skin diseases at the application site; clinically significant elevation … abuse; lactation; concomitant skin disease at application site; corticosteroid use; use of another … ethanol; clinically active renal, hepatic, or peptic ulcer disease; a history of alcohol or other
drug … abuse; lactation; concomitant skin disease at the application site; corticosteroid use, including oral
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-protocol.pdf
June 01, 2023 - That panel will be convened by the Substance Abuse and
Mental Health Services Administration (SAMHSA
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
February 07, 2018 - impairment
• Nursing home setting
• ≥2 physical (i.e. non-psychiatric) comorbidities
• History of substance … abuse
• Frailty
• Early versus late onset MDD
• Polypharmacy, defined as 5 or more concurrent prescription
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
April 01, 2022 - (e.g., age, race, ethnicity, sex, socioeconomic status)
• Comorbidities, including past or current substance … use disorders, mental health disorders,
medical comorbidities, and high risk for opioid use disorder
-
effectivehealthcare.ahrq.gov/products/cognitive-decline/research-protocol
March 23, 2016 - physical activity, education and intellectual engagement, social engagement, alcohol, smoking, and substance … abuse, medications, and vitamins.
-
effectivehealthcare.ahrq.gov/products/binge-eating/research-protocol
July 21, 2014 - and weight concerns, restraint, hunger, disinhibition
Depressive disorders and symptoms
Anxiety
Substance … abuse
Physical health and functioning
BMI, weight status or stabilization
Hypertension
Type … Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
September 01, 2017 - For KQ 5, co-occurring disorders include other mental
health or substance use disorders (e.g., depression … Journal of substance
abuse treatment. 2015;52:24-30.
27.
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_0.pdf
April 01, 2020 - such as females only, those
with treatment-resistant depression, those with
a comorbid disorder like substance … use disorder,
or those with exposure to a traumatic life event. … Moderators of fluoxetine treatment response for children
and adolescents with comorbid depression and substance … use disorders.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
April 01, 2020 - such as females only, those
with treatment-resistant depression, those with
a comorbid disorder like substance … use disorder,
or those with exposure to a traumatic life event. … Moderators of fluoxetine treatment response for children
and adolescents with comorbid depression and substance … use disorders.